Full-Time

Account Executive

Partnerships

Confirmed live in the last 24 hours

Chai Discovery

Chai Discovery

11-50 employees

Develops AI models for molecular predictions

No salary listed

Mid, Senior

San Francisco, CA, USA

In Person

Category
Strategic Account Management
Sales & Account Management
Requirements
  • 3-5 years in partnership management, strategic accounts, or enterprise SaaS sales, ideally within biotech, CRO, or life-science tooling
  • Track record exceeding quota / renewal targets by driving value for complex, multi-stakeholder accounts
  • Strong communicator able to switch fluently between scientists, executives, and procurement teams
  • Skilled at identifying expansion opportunities based on partner feedback and milestone achievements
  • Familiar with basic contract-lifecycle management systems
  • Comfortable mapping decision makers, drafting action plans, and escalating risks early
  • Experience coordinating legal, finance, and technical resources to keep timelines on track
  • Resourceful, detail-oriented, and energized by closing the gap between promise and delivery
  • Enjoys working in a fast-moving start-up where priorities can shift week to week
Responsibilities
  • Shepherd deals from late-stage negotiation through launch and long-term execution
  • Remove roadblocks and align internal and external teams
  • Ensure that each collaboration delivers on its scientific and commercial milestones

Chai Discovery develops AI foundation models that focus on predicting and reprogramming interactions between biochemical molecules, which are crucial for life. Their main product, Chai 1, is a multimodal model that can predict various molecular structures, such as proteins, small molecules, DNA, RNA, and covalent modifications. This model is available for free through a web interface, making it accessible for both academic researchers and pharmaceutical companies involved in drug discovery. Unlike many competitors, Chai Discovery emphasizes a user-friendly platform that allows clients to easily integrate AI into their research and development processes. The company's goal is to enhance the efficiency of molecular research and drug discovery through advanced AI technology.

Company Size

11-50

Company Stage

Seed

Total Funding

$30M

Headquarters

San Francisco, California

Founded

2024

Simplify Jobs

Simplify's Take

What believers are saying

  • Recent $30 million investment boosts Chai Discovery's growth and development potential.
  • Growing demand for AI in drug discovery enhances Chai Discovery's market opportunities.
  • Partnerships with pharmaceutical companies can accelerate R&D processes using Chai 1.

What critics are saying

  • Increased competition from well-funded AI drug discovery startups threatens market position.
  • Rapid technological advancements may render current models obsolete without updates.
  • Dependence on commercial licensing makes revenue vulnerable to industry trend shifts.

What makes Chai Discovery unique

  • Chai Discovery offers a free web-accessible AI model for molecular structure prediction.
  • Chai 1 excels in predicting proteins, small molecules, DNA, RNA, and covalent modifications.
  • The company serves both academic researchers and pharmaceutical companies with its AI platform.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Company Equity

Professional Development Budget

Wellness Program

Company News

Yahoo Finance
Sep 11th, 2024
OpenAI, Thrive Capital Back Six-Month-Old AI Drug Discovery Startup

(Bloomberg) -- Chai Discovery, an artificial intelligence biology startup founded six months ago, has raised nearly $30 million from heavyweights Thrive Capital and OpenAI to bring AI to drug discovery.Most Read from BloombergHow Americans Voted Their Way Into a Housing CrisisAfter a Record Hot Summer, Pressure Grows for A/C MandatesChicago Halts Hiring as Deficit Tops $1 Billion Through 2025UC Berkeley Gives Transfer Students a Purpose-Built Home on CampusChai develops AI foundation models that